Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2021 Dec 20;40:396. doi: 10.1186/s13046-021-02218-9

Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy

Xin Peng 1,2,3,#, Shaolu Zhang 1,2,4,#, Wenhui Jiao 1,2, Zhenxing Zhong 1,2, Yuqi Yang 5, Francois X Claret 3, Moshe Elkabets 6, Feng Wang 7, Ran Wang 1,2,, Yuxu Zhong 4,, Zhe-Sheng Chen 5,, Dexin Kong 1,2,8,
PMCID: PMC8686337  PMID: 34930384

Correction to: J Exp Clin Cancer Res 40, 374 (2021)

https://doi.org/10.1186/s13046-021-02176-2

Following publication of the original article [1], author found an error about the information of the last author, Dexin Kong, which was made in the production stage of the publication. The information indicating Dexin Kong as a corresponding author was missing, including the symbol "*" on his name and his email address. Such information has been added.

The correction does not have any effect on the results or conclusions of the paper. The original article has been corrected.

Footnotes

Xin Peng and Shaolu Zhang contributed equally to this work.

Contributor Information

Ran Wang, Email: wangran@tmu.edu.cn.

Yuxu Zhong, Email: yuxuzhong2008@aliyun.com.

Zhe-Sheng Chen, Email: chenz@stjohns.edu.

Dexin Kong, Email: kongdexin@tmu.edu.cn.

Reference

  • 1.Peng X, Zhang S, Jiao W, et al. Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy. J Exp Clin Cancer Res. 2021;40:374. doi: 10.1186/s13046-021-02176-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES